Security
BETR · BetterLife Pharma Inc.
BETRCSECommon stockCurrentCIK 1464165Updated Sep 27, 2026
Name history
Pivot Pharmaceuticals Inc. · through Dec 3, 2019Neurokine Pharmaceuticals Inc. · through Mar 26, 2015
BETR price & chart
Loading TradingView…
CSE:BETR on TradingView ↗In the news
No coverage from other publishers is available.
Financials
FY 2025 · CADSource
Source
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Profit or LossCAD | -3,621,884Source | -2,898,510Source | -9,372,772Source | -12,159,174Source |
| Additional Financial Items | ||||
| AdjustmentsForDecreaseIncreaseInTradeAccountReceivableCAD | 27,911Source | -22,350Source | — | — |
| AdjustmentsForIncomeTaxExpenseCAD | 0Source | 0Source | — | — |
| AdjustmentsForIncreaseDecreaseInTradeAccountPayableCAD | — | -701,563Source | — | — |
| AdjustmentsForSharebasedPaymentsCAD | 2,049,925Source | 500,263Source | — | — |
| GeneralAndAdministrativeExpenseCAD | 260,500Source | 271,731Source | 280,467Source | 425,865Source |
| InterestPaidClassifiedAsFinancingActivitiesCAD | — | — | 0Source | 0Source |
| PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivitiesCAD | — | — | -499,929Source | -499,929Source |
| ProceedsFromIssuingSharesCAD | 705,000Source | — | — | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Additional Financial Items | ||||
| CurrentTaxExpenseIncomeCAD | — | 0Source | — | -166,666Source |
| DepreciationAndAmortisationExpenseCAD | 0Source | 0Source | — | — |
| DilutedEarningsLossPerShareCAD/shares | -0.03Source | -0.03Source | -0.1Source | -0.16Source |
| GeneralAndAdministrativeExpenseCAD | 260,500Source | 271,731Source | 280,467Source | 425,865Source |
| ImpairmentLossRecognisedInProfitOrLossGoodwillCAD | — | — | — | -480,728Source |
| InterestExpenseCAD | 165,087Source | 45,544Source | 11,491Source | 51,761Source |
| NetForeignExchangeLossCAD | 275,182Source | 30,352Source | 203,212Source | 238,206Source |
| OperatingLeaseIncomeCAD | — | — | 0Source | 0Source |
| ProfessionalFeesExpenseCAD | 499,307Source | 526,503Source | 895,379Source | 879,054Source |
| ProfitLossAttributableToNoncontrollingInterestsCAD | -101,596Source | — | — | — |
| ProfitLossBeforeTaxCAD | — | -2,898,510Source | -9,372,772Source | -11,992,508Source |
| ProfitLossFromOperatingActivitiesCAD | -5,000,113Source | — | — | — |
| ResearchAndDevelopmentExpenseCAD | 424,337Source | 570,947Source | 2,677,286Source | 5,420,634Source |